Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
A new therapeutic approach called vascular-targeted photodynamic therapy (VTP) could be used to treat early-stage prostate cancer according to a study published in the leading medical journal The Lancet Oncology. ... Read more
Bipolar androgen therapy, a technique where the body is alternately flooded with and starved of testosterone, is safe and effective for the treatment of metastatic prostate cancer according to a ... Read more
Androgen deprivation therapy (ADT) may increase the risk of death among African American men who have prostate cancer according to a study published in the scientific journal Cancer. This may ... Read more
Men with very high-risk prostate cancer who are diagnosed and treated in hospitals where radical local treatments such as full-dose radiotherapy and prostatectomy (surgical removal of the prostate) are widely ... Read more
Researchers at the University of California Santa Cruz, in collaboration with colleagues at the University of California, Los Angeles (UCLA) generated a detailed map of how genes and proteins interact ... Read more
Immunotherapy with pembrolizumab, an antibody that blocks PD-1 signaling, may also work for advanced-stage prostate cancer, according to a preliminary study conducted by researchers at Oregon Health and Science University ... Read more